Hilltop National Bank Sells 5,859 Shares of Zoetis Inc. $ZTS

Hilltop National Bank reduced its position in shares of Zoetis Inc. (NYSE:ZTS) by 96.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 209 shares of the company’s stock after selling 5,859 shares during the period. Hilltop National Bank’s holdings in Zoetis were worth $26,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in ZTS. CIBC Asset Management Inc grew its holdings in shares of Zoetis by 4.3% during the 3rd quarter. CIBC Asset Management Inc now owns 251,495 shares of the company’s stock valued at $36,745,000 after purchasing an additional 10,434 shares during the last quarter. Mitsubishi UFJ Trust & Banking Corp increased its position in Zoetis by 6.5% during the 3rd quarter. Mitsubishi UFJ Trust & Banking Corp now owns 295,482 shares of the company’s stock worth $43,235,000 after purchasing an additional 18,040 shares in the last quarter. Quilter Plc lifted its stake in Zoetis by 10.2% in the 3rd quarter. Quilter Plc now owns 438,959 shares of the company’s stock valued at $64,228,000 after purchasing an additional 40,615 shares during the last quarter. Ninety One UK Ltd lifted its stake in Zoetis by 19.6% in the 3rd quarter. Ninety One UK Ltd now owns 1,119,132 shares of the company’s stock valued at $163,751,000 after purchasing an additional 183,686 shares during the last quarter. Finally, Swedbank AB boosted its position in Zoetis by 60.4% in the third quarter. Swedbank AB now owns 2,436,888 shares of the company’s stock valued at $356,565,000 after buying an additional 917,598 shares in the last quarter. 92.80% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

ZTS has been the subject of several research analyst reports. Morgan Stanley set a $160.00 price target on shares of Zoetis in a report on Thursday, December 18th. Piper Sandler restated a “neutral” rating and set a $135.00 price objective (down from $190.00) on shares of Zoetis in a research report on Thursday, January 22nd. Weiss Ratings raised Zoetis from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, March 12th. Bank of America increased their target price on Zoetis from $135.00 to $140.00 and gave the company a “neutral” rating in a research report on Friday, February 13th. Finally, Wall Street Zen raised Zoetis from a “hold” rating to a “buy” rating in a research note on Saturday, February 21st. Six investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Zoetis currently has a consensus rating of “Hold” and a consensus target price of $152.91.

Zoetis Stock Performance

Shares of Zoetis stock opened at $115.43 on Monday. The stock has a market cap of $48.73 billion, a price-to-earnings ratio of 19.17, a P/E/G ratio of 1.77 and a beta of 0.95. Zoetis Inc. has a twelve month low of $114.36 and a twelve month high of $172.23. The company’s fifty day moving average is $124.35 and its 200 day moving average is $130.29. The company has a quick ratio of 1.94, a current ratio of 3.03 and a debt-to-equity ratio of 2.71.

Zoetis (NYSE:ZTS) last announced its earnings results on Thursday, February 12th. The company reported $1.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.08. The business had revenue of $2.39 billion during the quarter, compared to analyst estimates of $2.36 billion. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.Zoetis’s revenue for the quarter was up 3.0% compared to the same quarter last year. During the same period last year, the company earned $1.40 EPS. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. Sell-side analysts forecast that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 2nd. Investors of record on Monday, April 20th will be paid a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend is Monday, April 20th. Zoetis’s payout ratio is currently 35.22%.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.